Furthermore, novel pathogenic variants of AKR1D1, LIPC, and SERPINE1, associated with congenital bile acid synthesis defects, abnormal circulating lipid concentrations, and plasminogen activator inhibitor type 1 deficiency conditions, were identified. Here, AKR1D1 is linked to hyperinsulinemic hypoglycemia, familial, 4.